Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eisuke Adachi

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
JMA Journal|February 12, 2026
Crisis Management of Emerging/Re-Emerging Infectious Diseases in People with HIV in JapanEisuke Adachi, Hiroshi Yotsuyanagi, Tomoya Saito
International Journal of STD & AIDS|October 31, 2025
Simultaneous detection of p24 antigen and antibody outside the acute phase of HIV infection: A case reportEisuke Adachi, Hiroshi Yotsuyanagi, Etsuko Nagai
Advances in Experimental Medicine and Biology|May 30, 2013
A computational approach to the dynamic aspects of primitive auditory scene analysisMakio Kashino, Eisuke Adachi, Haruto Hirose
The American Journal of Tropical Medicine and Hygiene|July 29, 2025
Colonoscopy-Based Diagnosis of Dibothriocephalus nihonkaiensis Infection Protruding into the Ascending ColonEisuke Adachi, Hiroyuki Nagai, Makoto Saito, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 23, 2025
High rate of HCV reinfection and the efficacy of standard regimens in men who have sex with men living with HIVEisuke Adachi, Yoshiaki Kanno, Michiko Koga, et al.
AIDS Research and Human Retroviruses|October 27, 2022
Changes in Inflammatory Biomarkers When Switching from Three-Drug Regimens to Dolutegravir Plus Lamivudine in People Living with HIVEisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2022
Background factors in people living with HIV in Japan who switch to cabotegravir plus rilpivirine: A pilot studyEisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga, et al.
AIDS Research and Therapy|January 4, 2024
Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirineEisuke Adachi, Makoto Saito, Amato Otani, et al.
Global Health & Medicine|May 1, 2024
Crisis management for the future: Building a platform to provide information on emerging and re-emerging infectious diseases from normal times in JapanEisuke Adachi, Amato Otani, Hiroshi Yotsuyanagi, et al.
AIDS Research and Human Retroviruses|January 2, 2024
Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus RilpivirineEisuke Adachi, Makoto Saito, Amato Otani, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
JMA Journal|February 12, 2026
Crisis Management of Emerging/Re-Emerging Infectious Diseases in People with HIV in JapanEisuke Adachi, Hiroshi Yotsuyanagi, Tomoya Saito
International Journal of STD & AIDS|October 31, 2025
Simultaneous detection of p24 antigen and antibody outside the acute phase of HIV infection: A case reportEisuke Adachi, Hiroshi Yotsuyanagi, Etsuko Nagai
Advances in Experimental Medicine and Biology|May 30, 2013
A computational approach to the dynamic aspects of primitive auditory scene analysisMakio Kashino, Eisuke Adachi, Haruto Hirose
The American Journal of Tropical Medicine and Hygiene|July 29, 2025
Colonoscopy-Based Diagnosis of Dibothriocephalus nihonkaiensis Infection Protruding into the Ascending ColonEisuke Adachi, Hiroyuki Nagai, Makoto Saito, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 23, 2025
High rate of HCV reinfection and the efficacy of standard regimens in men who have sex with men living with HIVEisuke Adachi, Yoshiaki Kanno, Michiko Koga, et al.
AIDS Research and Human Retroviruses|October 27, 2022
Changes in Inflammatory Biomarkers When Switching from Three-Drug Regimens to Dolutegravir Plus Lamivudine in People Living with HIVEisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2022
Background factors in people living with HIV in Japan who switch to cabotegravir plus rilpivirine: A pilot studyEisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga, et al.
AIDS Research and Therapy|January 4, 2024
Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirineEisuke Adachi, Makoto Saito, Amato Otani, et al.
Global Health & Medicine|May 1, 2024
Crisis management for the future: Building a platform to provide information on emerging and re-emerging infectious diseases from normal times in JapanEisuke Adachi, Amato Otani, Hiroshi Yotsuyanagi, et al.
AIDS Research and Human Retroviruses|January 2, 2024
Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus RilpivirineEisuke Adachi, Makoto Saito, Amato Otani, et al.
Pageof 12